Justin G Kusiel

Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer

A. Regev, E. Winer, O. Cohen, 2019, Clinical Cancer Research.

Abstract PD4-01: The role of FGF/FGFR axis in resistance to SERDs and CDK4/6 inhibitors in ER+ breast cancer

O. Cohen, Pingping Mao, N. Wagle, 2018 .